Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011

<p>Abstract</p> <p>Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. T...

Full description

Bibliographic Details
Main Authors: Ruffin Nicolas, Borggren Marie, Euler Zelda, Fiorino Fabio, Grupping Katrijn, Hallengärd David, Javed Aneele, Mendonca Kevin, Pollard Charlotte, Reinhart David, Saba Elisa, Sheik-Khalil Enas, Sköld Annette, Ziglio Serena, Scarlatti Gabriella, Gotch Frances, Wahren Britta, Shattock Robin J
Format: Article
Language:English
Published: BMC 2012-07-01
Series:Journal of Translational Medicine
Subjects:
HIV
Online Access:http://www.translational-medicine.com/content/10/1/144
id doaj-2986b1eb657846f5bf0298c3cd5021dc
record_format Article
spelling doaj-2986b1eb657846f5bf0298c3cd5021dc2020-11-25T00:25:00ZengBMCJournal of Translational Medicine1479-58762012-07-0110114410.1186/1479-5876-10-144Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011Ruffin NicolasBorggren MarieEuler ZeldaFiorino FabioGrupping KatrijnHallengärd DavidJaved AneeleMendonca KevinPollard CharlotteReinhart DavidSaba ElisaSheik-Khalil EnasSköld AnnetteZiglio SerenaScarlatti GabriellaGotch FrancesWahren BrittaShattock Robin J<p>Abstract</p> <p>Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These – necessarily overlapping topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.</p> http://www.translational-medicine.com/content/10/1/144HIVVaccineMicrobicidePrEP
collection DOAJ
language English
format Article
sources DOAJ
author Ruffin Nicolas
Borggren Marie
Euler Zelda
Fiorino Fabio
Grupping Katrijn
Hallengärd David
Javed Aneele
Mendonca Kevin
Pollard Charlotte
Reinhart David
Saba Elisa
Sheik-Khalil Enas
Sköld Annette
Ziglio Serena
Scarlatti Gabriella
Gotch Frances
Wahren Britta
Shattock Robin J
spellingShingle Ruffin Nicolas
Borggren Marie
Euler Zelda
Fiorino Fabio
Grupping Katrijn
Hallengärd David
Javed Aneele
Mendonca Kevin
Pollard Charlotte
Reinhart David
Saba Elisa
Sheik-Khalil Enas
Sköld Annette
Ziglio Serena
Scarlatti Gabriella
Gotch Frances
Wahren Britta
Shattock Robin J
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
Journal of Translational Medicine
HIV
Vaccine
Microbicide
PrEP
author_facet Ruffin Nicolas
Borggren Marie
Euler Zelda
Fiorino Fabio
Grupping Katrijn
Hallengärd David
Javed Aneele
Mendonca Kevin
Pollard Charlotte
Reinhart David
Saba Elisa
Sheik-Khalil Enas
Sköld Annette
Ziglio Serena
Scarlatti Gabriella
Gotch Frances
Wahren Britta
Shattock Robin J
author_sort Ruffin Nicolas
title Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
title_short Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
title_full Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
title_fullStr Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
title_full_unstemmed Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
title_sort rational design of hiv vaccines and microbicides: report of the europrise annual conference 2011
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2012-07-01
description <p>Abstract</p> <p>Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These – necessarily overlapping topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.</p>
topic HIV
Vaccine
Microbicide
PrEP
url http://www.translational-medicine.com/content/10/1/144
work_keys_str_mv AT ruffinnicolas rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT borggrenmarie rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT eulerzelda rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT fiorinofabio rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT gruppingkatrijn rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT hallengarddavid rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT javedaneele rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT mendoncakevin rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT pollardcharlotte rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT reinhartdavid rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT sabaelisa rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT sheikkhalilenas rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT skoldannette rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT ziglioserena rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT scarlattigabriella rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT gotchfrances rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT wahrenbritta rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
AT shattockrobinj rationaldesignofhivvaccinesandmicrobicidesreportoftheeuropriseannualconference2011
_version_ 1725350435642933248